CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Co-cultures on HS-5 protected CP-CML CD34+ and normal CD34+ cells from undergoing apoptosis in response to TKIs and BMP pathway inhibition (Fig. 3A-iv).